FDA clears Teva's copy of asthma medicine by AstraZeneca

11/20/2008 | Google

The FDA is allowing Teva Pharmaceutical Industries to market its version of AstraZeneca's Pulmicort Respules, an asthma drug for children. AstraZeneca filed a patent-infringement suit against Teva over the product, and a court hearing is scheduled for Jan. 12.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
Washington DC, DC
Director, Corporate Counsel
Tarrytown, NY